STING1 and metabolic dysfunction-associated steatohepatitis: Therefore, the cGAS-STING signaling pathway may be a key trigger of inflammatory responses in NASH progression and a potential new therapeutic target for NASH (Luo et al., 2018; Wang X. et al., 2020).